Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 14, 2022 06:30 ET | Source: Collegium Pharmaceutical, Inc.

Collegium to Acquire BioDelivery Sciences Broadening Pain Portfolio

- Expected to be Immediately and Highly Accretive Driven by Identified Annual Synergies of at Least $75 Million - - Will Diversify Revenue Growth and Accelerate Cash Flow Generation - - Addition of...
February 10, 2022 16:01 ET | Source: Collegium Pharmaceutical, Inc.

Collegium to Host Conference Call to Discuss Fourth Quarter and Full-Year 2021 Financial Results

STOUGHTON, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that the Company will host a conference call and live audio webcast on Thursday,...
December 28, 2021 08:00 ET | Source: Collegium Pharmaceutical, Inc.

Collegium Announces Settlement Framework to Resolve Pending Opioid-Related Litigation

STOUGHTON, Mass., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
December 06, 2021 09:29 ET | Source: Collegium Pharmaceutical, Inc.

Collegium Ranks as a Top Place to Work for 2021 by The Boston Globe

STOUGHTON, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
November 15, 2021 08:30 ET | Source: Collegium Pharmaceutical, Inc.

Collegium Announces $25 Million Accelerated Share Repurchase Program

STOUGHTON, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
November 11, 2021 16:54 ET | Source: Collegium Pharmaceutical, Inc.

UPDATE: Collegium to Participate in Upcoming Conferences

STOUGHTON, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
November 11, 2021 16:01 ET | Source: Collegium Pharmaceutical, Inc.

Collegium to Participate in Upcoming Conferences

STOUGHTON, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
November 04, 2021 16:01 ET | Source: Collegium Pharmaceutical, Inc.

Collegium Reports Third Quarter Fiscal 2021 Results

- Board of Directors Has Authorized $25 Million Accelerated Share Repurchase Program -- Net Income of $8.0 Million and Adjusted EBITDA of $37.3 Million -- Full-Year 2021 Guidance Updated -- Conference...
October 21, 2021 16:01 ET | Source: Collegium Pharmaceutical, Inc.

Collegium to Host Conference Call to Discuss Third Quarter 2021 Financial Results and Provide Corporate Update

STOUGHTON, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...
September 13, 2021 08:00 ET | Source: Collegium Pharmaceutical, Inc.

Collegium Announces Four Posters Presented at PAINWeek 2021 National Conference

STOUGHTON, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management,...